BTK inhibitors are associated with bacterial respiratory infections and opportunistic infections like Pneumocystis jirovecii pneumonia (PJP) and invasive fungal infections, due to BTK inhibition impairing immune cell signaling. Here, BTK is linked to pneumocystosis.